Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
COVID-19 pandemic caused by SARS-CoV-2 infection severely threatens global health and economic development. No effective antiviral drug is currently available to treat COVID-19 and any other human coronavirus infections. We report herein that a macrolide antibiotic, carrimycin, potently inhibited th...
Saved in:
Main Authors: | Haiyan Yan (Author), Jing Sun (Author), Kun Wang (Author), Huiqiang Wang (Author), Shuo Wu (Author), Linlin Bao (Author), Weiqing He (Author), Dong Wang (Author), Airu Zhu (Author), Tian Zhang (Author), Rongmei Gao (Author), Biao Dong (Author), Jianrui Li (Author), Lu Yang (Author), Ming Zhong (Author), Qi Lv (Author), Feifei Qin (Author), Zhen Zhuang (Author), Xiaofang Huang (Author), Xinyi Yang (Author), Yuhuan Li (Author), Yongsheng Che (Author), Jiandong Jiang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed -1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element
by: Hongying Li, et al.
Published: (2024) -
Synthesis and antiviral activities of a novel class of thioflavone and flavonoid analogues
by: Dajun Zhang, et al.
Published: (2012) -
Synthesis and antiviral activity of some novel indole-2-carboxylate derivatives
by: Situ Xue, et al.
Published: (2014) -
The antiviral effect of jiadifenoic acids C against coxsackievirus B3
by: Miao Ge, et al.
Published: (2014) -
Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
by: Yong Jin, et al.
Published: (2021)